CAT and liver cancer: To investigate whether the NQO1:CAT ratios are a potential therapeutic window in liver cancer, we analyzed NQO1 and CAT expression in liver hepatocellular carcinoma (LIHC) from The Cancer Genome Atlas (TCGA).